GUILDFORD, UNITED KINGDOM--(Marketwired - October 04, 2016) - ANGLE plc (AIM: AGL) (OTCQX: ANPCY)
ANGLE plc
(“ANGLE” or “the Company”)
Result of 2016 Annual General Meeting
ANGLE plc (AIM: AGL) (OTCQX: ANPCY), the specialist medtech company, announces that Resolutions 1 to 8 and Resolution 10 put to its shareholders at today’s 2016 Annual General Meeting were duly passed.
Resolution 9 in relation to an approved level for disapplication of statutory pre-emption rights was supported by the majority of Shareholders but did not receive the necessary level of support (75%) to be passed at this time. A reduced level for the disapplication of statutory pre-emption rights has been agreed with institutional shareholders and a further announcement will follow shortly seeking approval of this reduced level.
For further information:
ANGLE plc 01483 685830 Andrew Newland, Chief Executive Ian Griffiths, Finance Director Cenkos Securities 020 7397 8900 Stephen Keys (Nominated adviser) Russell Kerr, Oliver Baxendale (Sales) FTI Consulting Simon Conway, Mo Noonan, Stephanie Cuthbert 020 3727 1000 Kimberly Ha (US) 001 212 850 5612
Contact:
RNS
Customer Services
0044-207797-4400
rns@londonstockexchange.com
http://www.rns.com